TABLE 3.
Survival predictors in deep-learning model (feature set 3)
| Progression-free survival | Overall survival | ||
|---|---|---|---|
| Features | P value | Features | P value |
| Hysterectomya | 6.93E-69 | Radiotherapya | 8.04E-29 |
| Albumina | 2.53E-34 | Whitea | 4.25E-05 |
| Hemoglobina | 4.89E-32 | Hispanica | 6.27E-04 |
| Stage IVBa | 1.59E-27 | Hysterectomya | 2.19E-03 |
| Stage IA1a | 1.89E-27 | Bicarbonatea | 1.64E-02 |
| Stage IB1a | 8.61E-26 | Stage IVBa | 2.96E-02 |
| Chemotherapya | 2.33E-25 | Heart ratea | 3.17E-02 |
| Stage IIIBa | 4.09E-25 | Blood urea nitrogena | 4.33E-02 |
| Heart ratea | 5.16E-19 | Black | 5.42E-02 |
| Plateleta | 3.08E-17 | Platelet | 5.76E-02 |
| Radiotherapya | 1.14E-09 | Age | 6.83E-02 |
| White blood cella | 1.09E-08 | Chemotherapy | 7.07E-02 |
| Creatininea | 4.79E-08 | Creatinine | 7.62E-02 |
| Blood urea nitrogena | 1.78E-07 | Stage IIIA | 8.64E-02 |
| Bicarbonatea | 7.84E-07 | White blood cell | 1.05E-01 |
| Agea | 1.77E-05 | Stage IVA | 1.06E-01 |
| Stage IVAa | 5.83E-04 | Body mass index | 1.06E-01 |
| Blacka | 9.45E-04 | Hypercholesterolemia | 1.57E-01 |
| Hispanica | 1.00E-03 | Diabetes mellitus | 1.71E-01 |
| Other histologic conditionsa | 5.17E-03 | Systolic blood pressure | 1.80E-01 |
| Stage IIBa | 6.44E-03 | Stage IIA | 1.97E-01 |
| Hypertensiona | 1.30E-02 | Asian | 2.10E-01 |
| Body mass indexa | 1.61E-02 | Diastolic blood pressure | 2.40E-01 |
| Beta-blocker usea | 1.70E-02 | Stage IA1 | 2.68E-01 |
| Asiana | 3.65E-02 | Stage IIIB | 2.91E-01 |
| Adenocarcinomaa | 4.80E-02 | Other histologic conditions | 3.01E-01 |
| Hypercholesterolemia | 1.22E-01 | Stage IB1 | 3.58E-01 |
| Stage IB2 | 2.78E-01 | Beta-blocker | 3.66E-01 |
| Systolic blood pressure | 2.94E-01 | Squamous | 4.08E-01 |
| Squamous | 3.92E-01 | Adenocarcinoma | 4.28E-01 |
| Diastolic blood pressure | 4.14E-01 | Hypertension | 4.49E-01 |
| Diabetes mellitus | 4.87E-01 | Albumin | 4.62E-01 |
| Stage IIIA | 5.38E-01 | Stage IIB | 4.74E-01 |
| White | 5.53E-01 | Hemoglobin | 4.98E-01 |
| Adenosquamous | 6.18E-01 | Stage IB2 | 5.05E-01 |
| Stage IIA | 6.92E-01 | Adenosquamous | 5.54E-01 |
Covariates are listed based on the statistical significance.
a
Significant covariates (P<.05). Results for features sets 1 and 2 are shown in Supplemental Tables 2 and 3.